DUFRY AG NAM.-AKTIEN SF 5/ CH0023405456 /
24/06/2024 8:44:46 | Diferencia0.00 | Bid8:44:46 | Ask8:44:46 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
37.82EUR | 0.00% | 37.82 Volumen de oferta: - |
38.38 Tamaño/ Volumen/ Formato de Ask: - |
- | - - | - | - |
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
6:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
3:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
3:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página